Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / Fund iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker CUS1(GBX) LSE
ETF Ticker CUSS(USD) LSE
ETF Ticker SXRG(EUR) F
ETF Ticker CSUSS.MI(EUR) CXE
ETF Ticker CSUSSz(USD) CXE
ETF Ticker CUSS.LS(USD) CXE
ETF Ticker CSUSS(EUR) ETF Plus
ETF Ticker CUS1.L(GBP) LSE
ETF Ticker CUSS.L(GBP) LSE

Holdings detail for VCEL

Stock Name	Vericel Corp Ord
Ticker	VCEL(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US92346J1088
LEI	54930076YM3PLTDR4B91

Show aggregate VCEL holdings

News associated with VCEL

BTIG Research Downgrades Vericel (NASDAQ:VCEL) to Neutral: Vericel (NASDAQ:VCEL – Get Free Report) was downgraded by BTIG Research from a “buy” rating to a “neutral” rating in a note issued to investors on Wednesday, MarketBeat.com reports. VCEL has been the subject of a number of other research reports. Stephens reiterated an “overweight” rating and issued a $67.00 price objective on shares of […] - 2025-09-19 02:50:54
Vericel (NASDAQ:VCEL) Shares Gap Down Following Analyst Downgrade: Vericel Corporation (NASDAQ:VCEL – Get Free Report)’s share price gapped down prior to trading on Wednesday after BTIG Research downgraded the stock from a buy rating to a neutral rating. The stock had previously closed at $33.23, but opened at $31.85. Vericel shares last traded at $31.15, with a volume of 120,872 shares. A number […] - 2025-09-19 02:18:56
Vericel (NASDAQ:VCEL) Reaches New 52-Week Low on Analyst Downgrade: Vericel Corporation (NASDAQ:VCEL – Get Free Report) hit a new 52-week low during mid-day trading on Thursday after BTIG Research downgraded the stock from a buy rating to a neutral rating. The company traded as low as $29.93 and last traded at $30.02, with a volume of 1683483 shares traded. The stock had previously closed […] - 2025-09-18 03:06:42
Vericel Corporation (NASDAQ:VCEL) Given Average Recommendation of “Buy” by Brokerages: Vericel Corporation (NASDAQ:VCEL – Get Free Report) has earned an average recommendation of “Buy” from the six brokerages that are presently covering the firm, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy rating. The average 1 year price target among analysts that have covered the stock in the last year […] - 2025-08-21 04:24:45
Maryland State Retirement & Pension System Cuts Holdings in Vericel Corporation (NASDAQ:VCEL): Maryland State Retirement & Pension System trimmed its holdings in shares of Vericel Corporation (NASDAQ:VCEL – Free Report) by 13.1% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 14,387 shares of the biotechnology company’s stock after selling 2,170 shares during the […] - 2025-08-14 05:17:00
Vericel Corporation (NASDAQ:VCEL) Shares Bought by Mutual of America Capital Management LLC: Mutual of America Capital Management LLC grew its stake in Vericel Corporation (NASDAQ:VCEL – Free Report) by 5.9% during the 1st quarter, Holdings Channel reports. The fund owned 158,930 shares of the biotechnology company’s stock after acquiring an additional 8,789 shares during the period. Mutual of America Capital Management LLC’s holdings in Vericel were worth […] - 2025-08-08 04:30:54
Geneva Capital Management LLC Has $60.94 Million Stock Holdings in Vericel Corporation (NASDAQ:VCEL): Geneva Capital Management LLC grew its position in Vericel Corporation (NASDAQ:VCEL – Free Report) by 24.2% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,365,744 shares of the biotechnology company’s stock after purchasing an additional 265,956 shares during the quarter. Vericel […] - 2025-08-04 04:28:58
Envestnet Asset Management Inc. Raises Stock Position in Vericel Corporation (NASDAQ:VCEL): Envestnet Asset Management Inc. lifted its position in Vericel Corporation (NASDAQ:VCEL – Free Report) by 15.6% during the first quarter, Holdings Channel reports. The institutional investor owned 204,510 shares of the biotechnology company’s stock after buying an additional 27,526 shares during the quarter. Envestnet Asset Management Inc.’s holdings in Vericel were worth $9,125,000 as of […] - 2025-07-22 06:48:58
Principal Financial Group Inc. Grows Stake in Vericel Corporation (NASDAQ:VCEL): Principal Financial Group Inc. lifted its position in Vericel Corporation (NASDAQ:VCEL – Free Report) by 2.7% during the first quarter, HoldingsChannel.com reports. The institutional investor owned 270,154 shares of the biotechnology company’s stock after purchasing an additional 7,222 shares during the period. Principal Financial Group Inc.’s holdings in Vericel were worth $12,054,000 as of its […] - 2025-07-14 04:52:59
Vericel Corporation (NASDAQ:VCEL) Shares Sold by Amalgamated Bank: Amalgamated Bank trimmed its holdings in shares of Vericel Corporation (NASDAQ:VCEL – Free Report) by 2.6% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 14,010 shares of the biotechnology company’s stock after selling 375 shares during the quarter. Amalgamated […] - 2025-07-10 04:40:59
Oregon Public Employees Retirement Fund Cuts Holdings in Vericel Corporation (NASDAQ:VCEL): Oregon Public Employees Retirement Fund decreased its position in Vericel Corporation (NASDAQ:VCEL – Free Report) by 2.6% in the first quarter, Holdings Channel reports. The institutional investor owned 11,293 shares of the biotechnology company’s stock after selling 300 shares during the period. Oregon Public Employees Retirement Fund’s holdings in Vericel were worth $504,000 as of […] - 2025-07-08 05:24:54
Allspring Global Investments Holdings LLC Reduces Holdings in Vericel Corporation (NASDAQ:VCEL): Allspring Global Investments Holdings LLC trimmed its position in shares of Vericel Corporation (NASDAQ:VCEL – Free Report) by 4.5% in the 1st quarter, Holdings Channel reports. The institutional investor owned 249,441 shares of the biotechnology company’s stock after selling 11,632 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Vericel were worth $10,747,000 […] - 2025-07-04 04:52:25
Vericel Corporation (NASDAQ:VCEL) Given Average Rating of “Buy” by Brokerages: Shares of Vericel Corporation (NASDAQ:VCEL – Get Free Report) have been assigned an average recommendation of “Buy” from the seven ratings firms that are currently covering the stock, MarketBeat.com reports. Seven investment analysts have rated the stock with a buy rating. The average 12 month price objective among brokerages that have updated their coverage on […] - 2025-07-02 05:08:59
Vericel (NASDAQ:VCEL) Receives Overweight Rating from Stephens: Vericel (NASDAQ:VCEL – Get Free Report)‘s stock had its “overweight” rating restated by research analysts at Stephens in a research note issued on Monday,Benzinga reports. They presently have a $67.00 price objective on the biotechnology company’s stock. Stephens’ price objective would suggest a potential upside of 61.45% from the company’s previous close. A number of […] - 2025-06-18 03:02:52
GAMMA Investing LLC Has $5.76 Million Position in Vericel Co. (NASDAQ:VCEL): GAMMA Investing LLC raised its stake in shares of Vericel Co. (NASDAQ:VCEL – Free Report) by 5,916.5% in the 1st quarter, Holdings Channel.com reports. The institutional investor owned 129,175 shares of the biotechnology company’s stock after purchasing an additional 127,028 shares during the quarter. GAMMA Investing LLC’s holdings in Vericel were worth $5,764,000 at the […] - 2025-06-10 04:38:49
Brokerages Set Vericel Co. (NASDAQ:VCEL) Target Price at $61.14: Vericel Co. (NASDAQ:VCEL – Get Free Report) has been assigned a consensus rating of “Buy” from the seven research firms that are presently covering the stock, Marketbeat reports. Seven research analysts have rated the stock with a buy recommendation. The average 12-month price target among analysts that have covered the stock in the last year […] - 2025-06-10 03:14:49
Mackenzie Financial Corp Acquires New Stake in Vericel Co. (NASDAQ:VCEL): Mackenzie Financial Corp bought a new position in shares of Vericel Co. (NASDAQ:VCEL – Free Report) during the 4th quarter, HoldingsChannel reports. The institutional investor bought 3,924 shares of the biotechnology company’s stock, valued at approximately $215,000. A number of other hedge funds and other institutional investors also recently bought and sold shares of VCEL. […] - 2025-06-06 04:50:53
Vericel Co. (NASDAQ:VCEL) Shares Acquired by Deutsche Bank AG: Deutsche Bank AG grew its holdings in Vericel Co. (NASDAQ:VCEL – Free Report) by 32.1% in the 4th quarter, HoldingsChannel.com reports. The fund owned 52,999 shares of the biotechnology company’s stock after buying an additional 12,890 shares during the quarter. Deutsche Bank AG’s holdings in Vericel were worth $2,910,000 as of its most recent SEC […] - 2025-05-22 04:45:02
BNP Paribas Financial Markets Reduces Stake in Vericel Co. (NASDAQ:VCEL): BNP Paribas Financial Markets lowered its position in Vericel Co. (NASDAQ:VCEL – Free Report) by 35.1% in the 4th quarter, Holdings Channel reports. The fund owned 20,699 shares of the biotechnology company’s stock after selling 11,202 shares during the quarter. BNP Paribas Financial Markets’ holdings in Vericel were worth $1,137,000 as of its most recent […] - 2025-05-21 04:30:48
Vericel (NASDAQ:VCEL) Rating Lowered to “Sell” at StockNews.com: Vericel (NASDAQ:VCEL – Get Free Report) was downgraded by equities researchers at StockNews.com from a “hold” rating to a “sell” rating in a research note issued on Monday. VCEL has been the topic of a number of other research reports. Stephens reaffirmed an “overweight” rating and set a $65.00 target price on shares of Vericel […] - 2025-05-14 02:14:47
The Manufacturers Life Insurance Company Sells 526 Shares of Vericel Co. (NASDAQ:VCEL): The Manufacturers Life Insurance Company lowered its position in shares of Vericel Co. (NASDAQ:VCEL – Free Report) by 2.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 25,593 shares of the biotechnology company’s stock after selling 526 shares during […] - 2025-05-13 05:22:54
Price T Rowe Associates Inc. MD Decreases Stake in Vericel Co. (NASDAQ:VCEL): Price T Rowe Associates Inc. MD lowered its holdings in Vericel Co. (NASDAQ:VCEL – Free Report) by 2.9% during the fourth quarter, HoldingsChannel reports. The fund owned 29,479 shares of the biotechnology company’s stock after selling 868 shares during the period. Price T Rowe Associates Inc. MD’s holdings in Vericel were worth $1,619,000 as of […] - 2025-05-09 05:47:10
Vericel Co. (NASDAQ:VCEL) Stock Position Boosted by Mariner LLC: Mariner LLC grew its stake in shares of Vericel Co. (NASDAQ:VCEL – Free Report) by 7.7% during the fourth quarter, Holdings Channel reports. The institutional investor owned 9,209 shares of the biotechnology company’s stock after acquiring an additional 659 shares during the period. Mariner LLC’s holdings in Vericel were worth $506,000 at the end of […] - 2025-05-02 05:09:04
Renaissance Technologies LLC Buys 9,200 Shares of Vericel Co. (NASDAQ:VCEL): Renaissance Technologies LLC increased its stake in shares of Vericel Co. (NASDAQ:VCEL – Free Report) by 11.5% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 89,500 shares of the biotechnology company’s stock after purchasing an additional 9,200 shares during the period. Renaissance Technologies LLC’s […] - 2025-04-21 04:46:48
Brokerages Set Vericel Co. (NASDAQ:VCEL) Target Price at $60.86: Vericel Co. (NASDAQ:VCEL – Get Free Report) has received a consensus recommendation of “Buy” from the seven brokerages that are currently covering the company, Marketbeat reports. Seven research analysts have rated the stock with a buy recommendation. The average 1 year price target among analysts that have covered the stock in the last year is […] - 2025-04-21 02:30:46
Alliancebernstein L.P. Reduces Stake in Vericel Co. (NASDAQ:VCEL): Alliancebernstein L.P. reduced its stake in shares of Vericel Co. (NASDAQ:VCEL – Free Report) by 5.5% in the fourth quarter, Holdings Channel reports. The fund owned 54,730 shares of the biotechnology company’s stock after selling 3,160 shares during the quarter. Alliancebernstein L.P.’s holdings in Vericel were worth $3,005,000 as of its most recent filing with […] - 2025-04-16 04:31:00
Vericel Co. (NASDAQ:VCEL) Shares Sold by Sei Investments Co.: Sei Investments Co. cut its stake in Vericel Co. (NASDAQ:VCEL – Free Report) by 8.2% in the fourth quarter, Holdings Channel reports. The firm owned 59,945 shares of the biotechnology company’s stock after selling 5,320 shares during the period. Sei Investments Co.’s holdings in Vericel were worth $3,291,000 as of its most recent filing with […] - 2025-04-04 06:28:59
Vericel Co. (NASDAQ:VCEL) Stake Reduced by Corebridge Financial Inc.: Corebridge Financial Inc. trimmed its holdings in Vericel Co. (NASDAQ:VCEL – Free Report) by 6.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 26,155 shares of the biotechnology company’s stock after selling 1,682 shares during the quarter. Corebridge Financial Inc.’s holdings in Vericel […] - 2025-04-04 05:41:01
Prudential Financial Inc. Sells 4,199 Shares of Vericel Co. (NASDAQ:VCEL): Prudential Financial Inc. decreased its holdings in shares of Vericel Co. (NASDAQ:VCEL – Free Report) by 7.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 50,004 shares of the biotechnology company’s stock after selling 4,199 shares during the period. […] - 2025-04-04 04:31:04
Avantax Advisory Services Inc. Purchases 234 Shares of Vericel Co. (NASDAQ:VCEL): Avantax Advisory Services Inc. boosted its position in Vericel Co. (NASDAQ:VCEL – Free Report) by 1.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 13,803 shares of the biotechnology company’s stock after acquiring an additional 234 shares during the period. Avantax […] - 2025-03-21 06:47:07

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc VCEL holdings

Date	Number of VCEL Shares Held	Base Market Value of VCEL Shares	Local Market Value of VCEL Shares	Change in VCEL Shares Held	Change in VCEL Base Value	Current Price per VCEL Share Held	Previous Price per VCEL Share Held
2025-09-26 (Friday)	4,341	USD 131,228	USD 131,228
2025-09-25 (Thursday)	4,341	USD 129,535	USD 129,535	0	USD -1,780	USD 29.8399	USD 30.2499
2025-09-24 (Wednesday)	4,341	USD 131,315	USD 131,315
2025-09-17 (Wednesday)	4,313	USD 129,476	USD 129,476	0	USD -13,845	USD 30.0199	USD 33.23
2025-09-16 (Tuesday)	4,313	USD 143,321	USD 143,321
2025-09-12 (Friday)	4,285	USD 137,891	USD 137,891
2025-09-11 (Thursday)	4,285	USD 143,676	USD 143,676

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of VCEL by Blackrock for IE00B3VWM098

Show aggregate share trades of VCEL

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-08-21 SELL -14 35.440* 46.69 Profit of 654 on sale
2025-07-31 BUY 42 34.940* 46.83
2025-06-30 SELL -28 42.550* 47.78 Profit of 1,338 on sale
2025-06-25 SELL -14 41.880* 47.90 Profit of 671 on sale
2025-06-20 SELL -28 42.020* 48.02 Profit of 1,345 on sale
2025-05-23 BUY 14 40.920* 48.96
2025-05-19 SELL -14 42.540* 49.20 Profit of 689 on sale
2025-05-15 SELL -42 41.490* 49.32 Profit of 2,072 on sale
2025-05-12 SELL -14 42.650* 49.50 Profit of 693 on sale
2025-05-09 SELL -14 41.730* 49.57 Profit of 694 on sale
2025-04-30 SELL -14 38.020* 50.26 Profit of 704 on sale
2025-04-24 SELL -28 41.090* 50.68 Profit of 1,419 on sale
2025-04-17 SELL -14 41.230* 51.21 Profit of 717 on sale
2025-04-15 SELL -42 42.015* 51.42 Profit of 2,160 on sale
2025-04-14 SELL -42 41.230* 51.53 Profit of 2,164 on sale
2025-04-09 SELL -56 44.240* 51.84 Profit of 2,903 on sale
2025-04-07 SELL -98 39.900* 52.13 Profit of 5,109 on sale
2025-04-04 SELL -140 41.920* 52.25 Profit of 7,315 on sale
2025-03-31 BUY 14 44.620* 52.55
2025-03-19 SELL -28 47.430* 53.17 Profit of 1,489 on sale
2025-03-14 SELL -84 45.380* 53.45 Profit of 4,490 on sale
2025-03-13 SELL -28 45.390* 53.56 Profit of 1,500 on sale
2025-03-12 SELL -476 45.810* 53.67 Profit of 25,548 on sale
2025-03-07 SELL -28 49.560* 53.89 Profit of 1,509 on sale
2025-03-06 SELL -42 48.760* 53.97 Profit of 2,267 on sale
2025-03-03 SELL -14 49.510* 54.13 Profit of 758 on sale
2025-02-28 SELL -84 51.290* 54.17 Profit of 4,550 on sale
2025-02-26 SELL -14 52.850* 54.27 Profit of 760 on sale
2025-02-25 SELL -42 52.520* 54.30 Profit of 2,281 on sale
2025-02-18 BUY 70 57.280* 54.19
2025-02-13 BUY 14 56.810* 54.02
2025-02-12 BUY 14 56.020* 53.98
2025-02-11 BUY 42 57.510* 53.91
2025-02-06 BUY 126 59.700* 53.58
2025-01-27 BUY 14 59.720* 52.27
2024-12-30 BUY 70 55.300* 51.78
2024-12-06 BUY 56 56.370* 51.28
2024-12-05 BUY 14 56.520* 51.10
2024-12-04 BUY 70 58.150* 50.85
2024-11-29 BUY 70 58.140* 49.95
2024-11-27 BUY 56 57.760* 49.27
2024-11-26 BUY 14 58.750* 48.84
2024-11-21 BUY 70 56.710* 47.37
2024-11-20 BUY 42 57.260* 46.82
2024-11-18 BUY 168 52.890* 45.88
2024-11-12 BUY 112 55.890* 45.21
2024-11-08 BUY 70 54.000* 44.58
2024-11-07 BUY 210 50.030* 44.16
2024-11-06 BUY 28 48.040* 43.84
2024-10-31 BUY 14 44.040* 43.62
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-08-21	SELL	-14	35.440*	46.69 Profit of 654 on sale
2025-07-31	BUY	42	34.940*	46.83
2025-06-30	SELL	-28	42.550*	47.78 Profit of 1,338 on sale
2025-06-25	SELL	-14	41.880*	47.90 Profit of 671 on sale
2025-06-20	SELL	-28	42.020*	48.02 Profit of 1,345 on sale
2025-05-23	BUY	14	40.920*	48.96
2025-05-19	SELL	-14	42.540*	49.20 Profit of 689 on sale
2025-05-15	SELL	-42	41.490*	49.32 Profit of 2,072 on sale
2025-05-12	SELL	-14	42.650*	49.50 Profit of 693 on sale
2025-05-09	SELL	-14	41.730*	49.57 Profit of 694 on sale
2025-04-30	SELL	-14	38.020*	50.26 Profit of 704 on sale
2025-04-24	SELL	-28	41.090*	50.68 Profit of 1,419 on sale
2025-04-17	SELL	-14	41.230*	51.21 Profit of 717 on sale
2025-04-15	SELL	-42	42.015*	51.42 Profit of 2,160 on sale
2025-04-14	SELL	-42	41.230*	51.53 Profit of 2,164 on sale
2025-04-09	SELL	-56	44.240*	51.84 Profit of 2,903 on sale
2025-04-07	SELL	-98	39.900*	52.13 Profit of 5,109 on sale
2025-04-04	SELL	-140	41.920*	52.25 Profit of 7,315 on sale
2025-03-31	BUY	14	44.620*	52.55
2025-03-19	SELL	-28	47.430*	53.17 Profit of 1,489 on sale
2025-03-14	SELL	-84	45.380*	53.45 Profit of 4,490 on sale
2025-03-13	SELL	-28	45.390*	53.56 Profit of 1,500 on sale
2025-03-12	SELL	-476	45.810*	53.67 Profit of 25,548 on sale
2025-03-07	SELL	-28	49.560*	53.89 Profit of 1,509 on sale
2025-03-06	SELL	-42	48.760*	53.97 Profit of 2,267 on sale
2025-03-03	SELL	-14	49.510*	54.13 Profit of 758 on sale
2025-02-28	SELL	-84	51.290*	54.17 Profit of 4,550 on sale
2025-02-26	SELL	-14	52.850*	54.27 Profit of 760 on sale
2025-02-25	SELL	-42	52.520*	54.30 Profit of 2,281 on sale
2025-02-18	BUY	70	57.280*	54.19
2025-02-13	BUY	14	56.810*	54.02
2025-02-12	BUY	14	56.020*	53.98
2025-02-11	BUY	42	57.510*	53.91
2025-02-06	BUY	126	59.700*	53.58
2025-01-27	BUY	14	59.720*	52.27
2024-12-30	BUY	70	55.300*	51.78
2024-12-06	BUY	56	56.370*	51.28
2024-12-05	BUY	14	56.520*	51.10
2024-12-04	BUY	70	58.150*	50.85
2024-11-29	BUY	70	58.140*	49.95
2024-11-27	BUY	56	57.760*	49.27
2024-11-26	BUY	14	58.750*	48.84
2024-11-21	BUY	70	56.710*	47.37
2024-11-20	BUY	42	57.260*	46.82
2024-11-18	BUY	168	52.890*	45.88
2024-11-12	BUY	112	55.890*	45.21
2024-11-08	BUY	70	54.000*	44.58
2024-11-07	BUY	210	50.030*	44.16
2024-11-06	BUY	28	48.040*	43.84
2024-10-31	BUY	14	44.040*	43.62

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of VCEL

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	224,250	38	329,502	68.1%
2025-09-18	210,642	4,505	422,656	49.8%
2025-09-17	498,057	18	848,500	58.7%
2025-09-16	247,690	103	604,158	41.0%
2025-09-15	250,454	2,198	479,717	52.2%
2025-09-12	226,773	0	440,921	51.4%
2025-09-11	434,580	0	1,188,986	36.6%
2025-09-10	217,511	4	507,036	42.9%
2025-09-09	154,922	1,002	432,147	35.8%
2025-09-08	119,006	0	262,990	45.3%
2025-09-05	205,601	0	280,269	73.4%
2025-09-04	194,429	0	640,877	30.3%
2025-09-03	164,172	465	276,644	59.3%
2025-09-02	115,485	0	201,163	57.4%
2025-08-29	79,439	0	137,361	57.8%
2025-08-28	73,132	0	128,831	56.8%
2025-08-27	224,056	330	450,386	49.7%
2025-08-26	220,373	0	479,253	46.0%
2025-08-25	109,655	0	154,175	71.1%
2025-08-22	231,253	0	366,466	63.1%
2025-08-21	270,342	34,260	440,518	61.4%
2025-08-20	61,162	800	88,729	68.9%
2025-08-19	55,652	350	83,440	66.7%
2025-08-18	223,281	0	397,650	56.2%
2025-08-15	152,782	0	279,452	54.7%
2025-08-14	121,231	43	191,225	63.4%
2025-08-13	155,539	0	317,598	49.0%
2025-08-12	99,112	6,742	139,272	71.2%
2025-08-11	127,401	0	226,595	56.2%
2025-08-08	108,400	0	153,589	70.6%
2025-08-07	158,721	777	213,186	74.5%
2025-08-06	144,941	169	222,689	65.1%
2025-08-05	113,364	0	155,460	72.9%
2025-08-04	202,114	0	265,406	76.2%
2025-08-01	209,380	4,620	311,185	67.3%
2025-07-31	458,933	6,157	947,634	48.4%
2025-07-30	201,101	400	266,955	75.3%
2025-07-29	156,116	34	217,866	71.7%
2025-07-28	126,810	33	181,312	69.9%
2025-07-25	66,015	0	116,396	56.7%
2025-07-24	98,110	197	186,190	52.7%
2025-07-23	190,556	0	299,773	63.6%
2025-07-22	94,561	2,782	216,240	43.7%
2025-07-21	98,734	0	243,030	40.6%
2025-07-18	90,833	60	240,256	37.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE